{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T23:11:42Z","timestamp":1687907502994},"reference-count":82,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1097\/rhu.0b013e318226a977","type":"journal-article","created":{"date-parts":[[2012,12,19]],"date-time":"2012-12-19T18:26:26Z","timestamp":1355941586000},"page":"256-265","source":"Crossref","is-referenced-by-count":4,"title":["Musculoskeletal Features of Lyme Disease"],"prefix":"10.1097","volume":"17","author":[{"given":"Leonard H.","family":"Sigal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210207","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.1780200102","article-title":"Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities.","volume":"20","author":"Steere","year":"1977","journal-title":"Arthritis Rheum"},{"key":"R2-6-20210207","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-86-6-685","article-title":"Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum.","volume":"86","author":"Steere","year":"1977","journal-title":"Ann Intern Med"},{"key":"R3-6-20210207","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/oxfordjournals.aje.a112625","article-title":"Erythema chronicum migrans and Lyme arthritis: epidemiologic evidence for a tick vector.","volume":"108","author":"Steere","year":"1978","journal-title":"Am J Epidemiol"},{"key":"R4-6-20210207","first-page":"104","article-title":"Verhandlungen der dermatologischen Gesellschaft zu Stockholm.","volume":"101","author":"Afzelius","year":"1910","journal-title":"Arch Dermatol Syphilis Berlin"},{"key":"R5-6-20210207","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1001\/archderm.1970.04000070106017","article-title":"Erythema chronicum migrans.","volume":"102","author":"Scrimenti","year":"1970","journal-title":"Arch Dermatol"},{"key":"R6-6-20210207","first-page":"235","article-title":"Successful treatment of erythema migrans Afzelius.","volume":"31","author":"Hollstrom","year":"1951","journal-title":"Acta Derm Venereol"},{"key":"R7-6-20210207","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-93-1-1","article-title":"Antibiotic therapy in Lyme disease.","volume":"93","author":"Steere","year":"1980","journal-title":"Ann Intern Med"},{"key":"R8-6-20210207","doi-asserted-by":"crossref","first-page":"22","DOI":"10.7326\/0003-4819-99-1-22","article-title":"Treatment of the early manifestations of Lyme disease.","volume":"99","author":"Steere","year":"1983","journal-title":"Ann Intern Med"},{"key":"R9-6-20210207","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM198504043121401","article-title":"Successful parenteral penicillin therapy of established Lyme arthritis.","volume":"312","author":"Steere","year":"1985","journal-title":"N Engl J Med"},{"key":"R10-6-20210207","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJM198303313081301","article-title":"The spirochetal etiology of Lyme disease.","volume":"308","author":"Steere","year":"1983","journal-title":"N Engl J Med"},{"key":"R11-6-20210207","first-page":"411","article-title":"Lyme disease: a worldwide borreliosis.","volume":"6","author":"Sigal","year":"1988","journal-title":"Clin Exp Rheumatol"},{"key":"R12-6-20210207","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev.immunol.15.1.63","article-title":"The immunology and potential mechanisms of immunopathogenesis of Lyme disease.","volume":"15","author":"Sigal","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"R13-6-20210207","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM200107123450207","article-title":"Lyme disease.","volume":"345","author":"Steere","year":"2001","journal-title":"New Engl J Med"},{"key":"R14-6-20210207","doi-asserted-by":"crossref","first-page":"725","DOI":"10.7326\/0003-4819-107-5-725","article-title":"The clinical evolution of Lyme arthritis.","volume":"107","author":"Steere","year":"1987","journal-title":"Ann Intern Med"},{"key":"R15-6-20210207","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1002\/art.22007","article-title":"Lyme myositis.","volume":"54","author":"Holmgren","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R16-6-20210207","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/infdis\/167.2.392","article-title":"Western blotting in the serodiagnosis of Lyme disease.","volume":"167","author":"Dressler","year":"1993","journal-title":"J Infect Dis"},{"key":"R17-6-20210207","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1128\/JCM.41.11.4955-4960.2003","article-title":"C6 test as an indicator of therapy outcome for patients with localized or disseminated Lyme borreliosis.","volume":"41","author":"Philipp","year":"2003","journal-title":"J Clin Microbiol"},{"key":"R18-6-20210207","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1128\/JCM.36.4.1074-1080.1998","article-title":"IgM capture assay for the serologic confirmation of early Lyme disease: analyzing immune complexes with biotinylated Borrelia burgdorferi sonicate enhanced with flagellin peptide epitope.","volume":"36","author":"Brunner","year":"1998","journal-title":"J Clin Microbiol"},{"key":"R19-6-20210207","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1086\/315724","article-title":"Immune complexes from Lyme disease sera contain Borrelia burgdorferi antigen and antigen-specific antibodies: potential use for improved testing.","volume":"182","author":"Brunner","year":"2000","journal-title":"J Infect Dis"},{"key":"R20-6-20210207","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1128\/JCM.39.9.3213-3221.2001","article-title":"Use of serum immune complexes in a new test that accurately confirms early Lyme disease and active infection with Borrelia burgdorferi.","volume":"39","author":"Brunner","year":"2001","journal-title":"J Clin Microbiol"},{"key":"R21-6-20210207","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1056\/NEJM197912203012502","article-title":"Immune complexes and the evolution of Lyme arthritis. Dissemination and localization of abnormal C1q binding activity.","volume":"301","author":"Hardin","year":"1979","journal-title":"N Engl J Med"},{"key":"R22-6-20210207","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1172\/JCI109324","article-title":"Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.","volume":"63","author":"Hardin","year":"1979","journal-title":"J Clin Invest"},{"key":"R23-6-20210207","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1086\/515382","article-title":"Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi.","volume":"178","author":"Rousselle","year":"1998","journal-title":"J Infect Dis"},{"key":"R24-6-20210207","first-page":"908","article-title":"Ability of borreliacidal antibody test to confirm Lyme disease in clinical practice.","volume":"9","author":"Callister","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"R25-6-20210207","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/CVI.00079-08","article-title":"Significantly improved accuracy of diagnosis of early Lyme disease by peptide enzyme-linked immunosorbent assay based on the borreliacidal antibody epitope of Borrelia burgdorferi OspC.","volume":"15","author":"Jobe","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"R26-6-20210207","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1128\/CVI.00167-09","article-title":"Natural killer cell counts are not different between patients with post-Lyme disease syndrome and controls published online ahead of print June 10, 2009.","volume":"16","author":"Marques","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"R27-6-20210207","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/art.1780290609","article-title":"Proliferative responses of mononuclear cells in Lyme disease: concentration of Borrelia burgdorferi-reactive cells in joint fluid.","volume":"29","author":"Sigal","year":"1986","journal-title":"Arthritis Rheum"},{"key":"R28-6-20210207","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/BF02770837","article-title":"A proposal for the reliable culture of Borrelia burgdorferi from patients with chronic Lyme disease, even from those previously aggressively treated.","volume":"26","author":"Phillips","year":"1998","journal-title":"Infection"},{"key":"R29-6-20210207","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/art.1780360514","article-title":"Identification of Borrelia burgdorferi using interrupted polymerase chain reaction.","volume":"36","author":"Nishio","year":"1993","journal-title":"Arthritis Rheum"},{"key":"R30-6-20210207","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199401273300401","article-title":"Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis.","volume":"330","author":"Nocton","year":"1994","journal-title":"N Engl J Med"},{"key":"R31-6-20210207","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1002\/1529-0131(199912)42:12<2705::AID-ANR29>3.0.CO;2-H","article-title":"Lack of Borrelia burgdorferi DNA in synovial fluid samples from patients with antibiotic-resistant Lyme arthritis.","volume":"42","author":"Carlson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R32-6-20210207","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1002\/1529-0131(200111)44:11<2463::AID-ART425>3.0.CO;2-8","article-title":"Synovial fluid polymerase chain reaction detection of pathogens: what does it really mean?","volume":"44","author":"Sigal","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R33-6-20210207","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0002-9343(90)90520-N","article-title":"Summary of the first one hundred patients seen at a Lyme disease referral center.","volume":"88","author":"Sigal","year":"1990","journal-title":"Am J Med"},{"key":"R35-6-20210207","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/anr.1780320902","article-title":"Immune responses to Borrelia burgdorferi in patients with reactive arthritis.","volume":"32","author":"Weyand","year":"1989","journal-title":"Arthritis Rheum"},{"key":"R36-6-20210207","first-page":"484","article-title":"Borrelia infection as a possible cause of HLA-B27 negative sacroiliitis.","volume":"18","author":"Kinigadner","year":"1991","journal-title":"J Rheumatol"},{"key":"R37-6-20210207","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/art.1780361103","article-title":"\"Chronic Lyme disease\" as the incorrect diagnosis in patients with fibromyalgia.","volume":"36","author":"Hsu","year":"1993","journal-title":"Arthritis Rheum"},{"key":"R38-6-20210207","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1542\/peds.90.4.523","article-title":"Lyme arthritis as the incorrect diagnosis in fibromyalgia in children and adolescents.","volume":"90","author":"Sigal","year":"1992","journal-title":"Pediatrics"},{"key":"R39-6-20210207","doi-asserted-by":"crossref","first-page":"503","DOI":"10.7326\/0003-4819-119-6-199309150-00010","article-title":"Empiric parenteral antibiotic treatment of patients with fibromyalgia and fatigue and a positive serologic result for Lyme disease. A cost-effectiveness analysis.","volume":"119","author":"Lightfoot","year":"1993","journal-title":"Ann Intern Med"},{"key":"R40-6-20210207","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/archinte.1996.00440130011002","article-title":"The Lyme disease controversy: the social and financial costs of the mismanagement of Lyme disease.","volume":"156","author":"Sigal","year":"1996","journal-title":"Arch Intern Med"},{"issue":"suppl 4","key":"R41-6-20210207","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1289\/ehp.02110s4607","article-title":"Contributions of societal and geographical environments to \"chronic Lyme disease\": the psychopathogenesis and aporology of a new \"medically unexplained symptoms\" syndrome.","volume":"110","author":"Sigal","year":"2002","journal-title":"Environ Health Perspect"},{"key":"R42-6-20210207","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0002-9343(94)90068-X","article-title":"Persisting complaints attributed to Lyme disease: possible mechanisms and implications for management.","volume":"96","author":"Sigal","year":"1994","journal-title":"Am J Med"},{"key":"R43-6-20210207","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1128\/AAC.49.4.1294-1301.2005","article-title":"In vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy.","volume":"49","author":"Hunfeld","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R44-6-20210207","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America published online ahead of print October 2, 2006.","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R45-6-20210207","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM200107123450202","article-title":"Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease.","volume":"345","author":"Klempner","year":"2001","journal-title":"N Engl J Med"},{"key":"R46-6-20210207","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1469-0691.2004.00895.x","article-title":"Lyme borreliosis: from infection to autoimmunity.","volume":"10","author":"Singh","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"R47-6-20210207","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.4049\/jimmunol.157.8.3534","article-title":"Detection of Borrelia burgdorferi-specific CD8+ cytotoxic T cells in patients with Lyme arthritis.","volume":"157","author":"Busch","year":"1996","journal-title":"J Immunol"},{"key":"R48-6-20210207","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF01409985","article-title":"Intracellular persistence of Borrelia burgdorferi in human synovial cells.","volume":"16","author":"Girschick","year":"1996","journal-title":"Rheumatol Int"},{"key":"R49-6-20210207","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.idc.2007.12.014","article-title":"Lyme arthritis: pathogenesis, clinical presentation, and management.","volume":"22","author":"Puius","year":"2008","journal-title":"Infect Dis Clin North Am"},{"key":"R50-6-20210207","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1600-0463.2004.apm1120110.x","article-title":"Induction of cystic forms by different stress conditions in Borrelia burgdorferi.","volume":"112","author":"Murgia","year":"2004","journal-title":"APMIS"},{"key":"R51-6-20210207","doi-asserted-by":"crossref","first-page":"18656","DOI":"10.1073\/pnas.0908236106","article-title":"Destruction of spirochete Borrelia burgdorferi round-body propagules (RBs) by the antibiotic tigecycline.","volume":"106","author":"Brorson","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R52-6-20210207","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10123-002-0055-2","article-title":"An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to hydroxychloroquine.","volume":"5","author":"Brorson","year":"2002","journal-title":"Int Microbiol"},{"key":"R53-6-20210207","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/art.22441","article-title":"High levels of inflammatory chemokines and cytokines in joint fluid and synovial tissue throughout the course of antibiotic-refractory Lyme arthritis.","volume":"56","author":"Shin","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R54-6-20210207","doi-asserted-by":"crossref","first-page":"5279","DOI":"10.4049\/jimmunol.0901390","article-title":"Recognition of Borrelia burgdorferi, the Lyme disease spirochete, by TLR7 and TLR9 induces a type I IFN response by human immune cells.","volume":"183","author":"Petzke","year":"2009","journal-title":"J Immunol"},{"key":"R55-6-20210207","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1002\/art.23972","article-title":"Borrelia burgdorferi NapA-driven TH17 cell inflammation in Lyme arthritis.","volume":"58","author":"Codolo","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R56-6-20210207","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/CVI.00330-07","article-title":"Lyme arthritis: current concepts and a change in paradigm.","volume":"15","author":"Nardelli","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"R57-6-20210207","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1574-695X.2008.00431.x","article-title":"Role of interleukin-17, transforming growth factor-, and IL-6 in the development of arthritis and production of anti-outer surface protein A borreliacidal antibodies in Borrelia-vaccinated and -challenged mice.","volume":"53","author":"Nardelli","year":"2008","journal-title":"FEMS Immunol Med Microbiol"},{"key":"R59-6-20210207","first-page":"648","article-title":"In vivo and in vitro evidence of B cell hyperactivity during Lyme disease.","volume":"15","author":"Sigal","year":"1988","journal-title":"J Rheumatol"},{"key":"R60-6-20210207","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1084\/jem.174.3.593","article-title":"Borrelia burgdorferi activates a T helper cell type-1-like T cell subset in Lyme arthritis.","volume":"174","author":"Yssel","year":"1991","journal-title":"J Exp Med"},{"key":"R61-6-20210207","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1126\/science.281.5377.703","article-title":"Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis.","volume":"281","author":"Gross","year":"1998","journal-title":"Science"},{"key":"R62-6-20210207","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/1529-0131(199909)42:9<1813::AID-ANR4>3.0.CO;2-0","article-title":"Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia burgdorferi.","volume":"42","author":"Chen","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R63-6-20210207","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/art.10772","article-title":"Binding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis.","volume":"48","author":"Steere","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R64-6-20210207","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/art.24418","article-title":"HLA type and immune response to Borrelia burgdorferi outer surface A protein in people in whom arthritis developed after Lyme disease vaccination.","volume":"60","author":"Ball","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R65-6-20210207","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1002\/art.25005","article-title":"HLA-DR alleles determine responsiveness to Borrelia burgdorferi antigens in a mouse model of self-perpetuating arthritis.","volume":"60","author":"Iliopoulou","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"suppl 3","key":"R66-6-20210207","doi-asserted-by":"crossref","first-page":"s259","DOI":"10.1093\/cid\/ciq117","article-title":"Relationship between immunity to Borrelia burgdorferi outer-surface protein A (OspA) and Lyme arthritis.","volume":"52","author":"Steere","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R67-6-20210207","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1006\/jaut.2000.0495","article-title":"Autoimmune mechanisms in antibiotic treatment-resistant Lyme arthritis.","volume":"16","author":"Steere","year":"2001","journal-title":"J Autoimmunity"},{"key":"R68-6-20210207","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1086\/346059","article-title":"Human T lymphocyte response to Borrelia burgdorferi infection: no correlation between human leukocyte function antigen type 1 peptide response and clinical status.","volume":"187","author":"Kalish","year":"2003","journal-title":"JID"},{"key":"R69-6-20210207","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/1521-4141(200002)30:2<448::AID-IMMU448>3.0.CO;2-9","article-title":"Multiple cross-reactive self-ligands for Borrelia burgdorferi-specific HLA-DR4-restricted T cells.","volume":"30","author":"Maier","year":"2000","journal-title":"Eur J Immunol"},{"key":"R70-6-20210207","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/ar1476","article-title":"The role and clinical implications of G6PI in experimental models of rheumatoid arthritis published online ahead of print November 30, 2004.","volume":"7","author":"Kamradt","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"R71-6-20210207","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0925-4439(93)90096-J","article-title":"Molecular mimicry in Lyme disease: monoclonal antibody H9724 to Borrelia burgdorferi flagellin specifically detects chaperonin-HSP60.","volume":"1181","author":"Dai","year":"1993","journal-title":"Biochim Biophys Acta"},{"key":"R72-6-20210207","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1073\/pnas.90.1.183","article-title":"Fine mapping of the serologic response to the Borrelia burgdorferi flagellin demonstrates an epitope common to neural tissue.","volume":"90","author":"Fikrig","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R73-6-20210207","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1212\/WNL.38.9.1439","article-title":"Molecular mimicry in Lyme neurologic disease: cross-reactivity between Borrelia burgdorferi and neuronal antigens.","volume":"38","author":"Sigal","year":"1988","journal-title":"Neurology"},{"key":"R74-6-20210207","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1749-6632.1988.tb31892.x","article-title":"IgM in the serum of patients with Lyme neurologic disease binds to cross-reacting neuronal (NAg) and Borrelia burgdorferi (BAg) antigens.","volume":"539","author":"Sigal","year":"1988","journal-title":"Ann N Y Acad Sci"},{"key":"R75-6-20210207","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/infdis\/167.6.1372","article-title":"The flagellin of Borrelia burgdorferi, the causative agent of Lyme disease, cross-reacts with a human axonal 64,000 molecular weight protein.","volume":"167","author":"Sigal","year":"1993","journal-title":"J Infect Dis"},{"key":"R76-6-20210207","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1056\/NEJM199004263221713","article-title":"Should we try malariotherapy for Lyme disease?","volume":"322","author":"Heimlich","year":"1990","journal-title":"N Engl J Med"},{"key":"R77-6-20210207","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000091726","article-title":"Lyme disease: the quest for magic bullets published online ahead of print February 22, 2006.","volume":"52","author":"Stricker","year":"2006","journal-title":"Chemotherapy"},{"issue":"suppl 2","key":"R78-6-20210207","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/joc.2005.17.Supplement-2.3","article-title":"Review of treatment options for Lyme borreliosis.","volume":"17","author":"Taylor","year":"2005","journal-title":"J Chemother"},{"key":"R79-6-20210207","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02850341","article-title":"COL40155 Study Team. Atovaquone plus cholestyramine in patients coinfected with Babesia microti and Borrelia burgdorferi refractory to other treatment.","volume":"23","author":"Shoemaker","year":"2006","journal-title":"Adv Ther"},{"key":"R80-6-20210207","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1002\/art.22131","article-title":"Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis.","volume":"54","author":"Steere","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R81-6-20210207","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/art.1780241217","article-title":"Treatment of chronic Lyme arthritis with hydroxychloroquine.","volume":"24","author":"Coblyn","year":"1981","journal-title":"Arthritis Rheum"},{"key":"R82-6-20210207","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1086\/518853","article-title":"Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with Lyme disease.","volume":"45","author":"Stricker","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R83-6-20210207","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3899\/jrheum.090711","article-title":"Outcomes of children treated for Lyme arthritis: results of a large pediatric cohort published online ahead of print April 1, 2010.","volume":"37","author":"Tory","year":"2010","journal-title":"J Rheumatol"},{"key":"R84-6-20210207","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/art.1780340817","article-title":"Treatment of refractory chronic Lyme arthritis with arthroscopic synovectomy.","volume":"34","author":"Schoen","year":"1991","journal-title":"Arthritis Rheum"}],"container-title":["JCR: Journal of Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RHU.0b013e318226a977","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T22:41:57Z","timestamp":1687905717000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00124743-201108000-00006"}},"subtitle":["Understanding the Pathogenesis of Clinical Findings Helps Make Appropriate Therapeutic Choices"],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":82,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/rhu.0b013e318226a977","relation":{},"ISSN":["1076-1608"],"issn-type":[{"value":"1076-1608","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}